⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8861393 | 1.00 | — | — | |
| SCHEMBL395468 | 0.55 | — | — | |
| SCHEMBL279868 | 0.54 | — | — | |
| SCHEMBL2693105 | 0.53 | — | — | |
| SCHEMBL31705500 | 0.50 | — | — | |
| SCHEMBL6299692 | 0.47 | — | — | |
| SCHEMBL452580 | 0.38 | — | — | |
| SCHEMBL570870 | 0.35 | — | — | |
| SCHEMBL347419 | 0.35 | — | — | |
| SCHEMBL561897 | 0.34 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4441811-A1 | CATHOLYTES FOR A SOLID-STATE BATTERY | QuantumScape Battery, Inc. (US) | 2024-10-09 | — | — | EP | claimed |
| CN-118318325-A | Catholyte for solid state battery | 昆腾斯科普电池公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2024077078-A2 | STERYLGLUCOSIDASE INHIBITING COMPOSITIONS AND METHOD OF USING | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-04-11 | — | — | WO | claimed |
| WO-2023121838-A1 | CATHOLYTES FOR A SOLID-STATE BATTERY | QUANTUMSCAPE BATTERY, INC. (US) | 2023-06-29 | — | — | WO | claimed |
| CN-107849055-A | Macrocyclic compound as IRAK1/4 inhibitor and application thereof | 默克专利有限公司 | 2018-03-27 | — | — | CN | claimed |
| US-8962830-B2 | Protein kinase inhibitors and methods of treatment | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2015-02-24 | — | — | US | claimed |
| US-20130184274-A1 | Protein Kinase Inhibitors and Methods of Treatment | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2013-07-18 | — | — | US | claimed |
| CN-102015675-A | Chlorothiophene amides as inhibitors of coagulation factors Xa and thrombin | SANOFI AVENTIS | 2011-04-13 | — | — | CN | claimed |
| CN-101981035-A | Triazolium salts as PAR1 inhibitors, their preparation and their use as medicaments | SANOFI AVENTIS | 2011-02-23 | — | — | CN | claimed |
| CN-101210016-A | Heterocycle-fused morphinans compounds, preparation method and use thereof | SHANGHAI INST OF MEDICINE CHIN (CN) | 2008-07-02 | — | — | CN | claimed |
| EP-1390340-A4 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-07-25 | — | — | EP | claimed |
| CN-1854128-A | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-11-01 | — | — | CN | claimed |
| US-6867298-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2005-03-15 | — | — | US | claimed |
| EP-1479676-A1 | Benzimidazole-derivatives as factor xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | claimed |
| CN-1518534-A | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | 麻省理工学院 | 2004-08-04 | — | — | CN | claimed |
| EP-1390340-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-02-25 | — | — | EP | claimed |
| US-20040019216-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-01-29 | — | — | US | claimed |
| US-20030065187-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-03 | — | — | US | claimed |
| WO-2002085838-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-10-31 | — | — | WO | claimed |
| EP-4731258-A1 | LIPID NANOPARTICLES CONTAINING DISULFIDE LIPIDS AND FORMULATIONS THEREOF | Providence Therapeutics Holdings Inc. (CA) | 2026-04-29 | — | — | EP | disclosed |
| US-12291606-B2 | Coordination polymers of coinage metals synthesis and uses thereof | Texas Woman's University (US) | 2025-05-06 | — | — | US | disclosed |
| US-20250006995-A1 | CATHOLYTES FOR A SOLID-STATE BATTERY | QUANTUMSCAPE BATTERY, INC. | 2025-01-02 | — | — | US | disclosed |
| WO-2024259531-A1 | LIPID NANOPARTICLES CONTAINING DISULFIDE LIPIDS AND FORMULATIONS THEREOF | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2024-12-26 | — | — | WO | disclosed |
| EP-4441811-A1 | CATHOLYTES FOR A SOLID-STATE BATTERY | QuantumScape Battery, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-118318325-A | Catholyte for solid state battery | 昆腾斯科普电池公司 | 2024-07-09 | — | — | CN | disclosed |
| US-11967676-B2 | Catholytes for a solid-state battery | QUANTUMSCAPE BATTERY, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| WO-2024077078-A2 | STERYLGLUCOSIDASE INHIBITING COMPOSITIONS AND METHOD OF USING | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20230327184-A1 | CATHOLYTES FOR A SOLID-STATE BATTERY | QUANTUMSCAPE BATTERY, INC. | 2023-10-12 | — | — | US | disclosed |
| WO-2023121838-A1 | CATHOLYTES FOR A SOLID-STATE BATTERY | QUANTUMSCAPE BATTERY, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| EP-3484462-B1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR SKIN AND/OR HAIR REPAIR | PASTEUR INSTITUT (FR) | 2022-12-14 | — | — | EP | disclosed |
| US-11344515-B2 | 5-hydroxytryptamine 1B receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiation | INSTITUT PASTEUR (FR) | 2022-05-31 | — | — | US | disclosed |
| EP-1436271-B3 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H LUNDBECK AS (DK) | 2022-04-20 | — | — | EP | disclosed |
| EP-3377051-B1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR ENHANCING IN VIVO ENGRAFTMENT POTENTIAL | PASTEUR INSTITUT (FR) | 2022-03-30 | — | — | EP | disclosed |
| WO-2022057930-A1 | BENZIMIDAZOLE COMPOUND HAVING ENDOTHELIAL LIPASE INHIBITION EFFECT, AND APPLICATION | 盐城师范学院 | 2022-03-24 | — | — | WO | disclosed |
| CN-114206340-A | Methods of treating follicular lymphoma using anti-CD 79B immunoconjugates | 豪夫迈·罗氏有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20210330863-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR ENHANCING IN VIVO ENGRAFTMENT POTENTIAL | UNIVERSITÉ PARIS CITÉ (FR) | 2021-10-28 | — | — | US | disclosed |
| US-20210276966-A1 | Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors | H. LUNDBECK A/S (DK) | 2021-09-09 | — | — | US | disclosed |
| US-20210214508-A1 | COORDINATION POLYMERS OF COINAGE METALS SYNTHESIS AND USES THEREOF | Texas Woman’s University | 2021-07-15 | — | — | US | disclosed |
| US-11013830-B2 | 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential | INSTITUT PASTEUR (FR) | 2021-05-25 | — | — | US | disclosed |
| EP-3799873-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | Institut Pasteur (FR) | 2021-04-07 | — | — | EP | disclosed |
| EP-3324952-B1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | PASTEUR INSTITUT (FR) | 2020-12-16 | — | — | EP | disclosed |
| US-10844029-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2020-11-24 | — | — | US | disclosed |
| EP-3138840-B1 | THIADIAZOLIDINE DERIVATIVE AS ANTI-ENTEROVIRUS 71 | JIANGSU KANION PHARMACEUTICAL CO LTD (CN) | 2020-09-23 | — | — | EP | disclosed |
| US-20200060999-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | Universite De Paris (FR) | 2020-02-27 | — | — | US | disclosed |
| US-20190290641-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR SKIN AND/OR HAIR REPAIR | Universite De Paris (FR) | 2019-09-26 | — | — | US | disclosed |
| CN-106255679-B | As NAThe heterocyclic compound and application thereof of V channel inhibitor | 默克专利有限公司 | 2019-09-06 | — | — | CN | disclosed |
| CN-110022869-A | For skin and/or the serotonin 1B receptor stimulators of hair reparation | 巴斯德研究院 | 2019-07-16 | — | — | CN | disclosed |
| CN-106068264-B | Pyrimidine pyrazolyl derivatives and their use as IRAK inhibitors | 默克专利有限公司 | 2019-06-21 | — | — | CN | disclosed |
| EP-3484462-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR SKIN AND/OR HAIR REPAIR | Institut Pasteur (FR) | 2019-05-22 | — | — | EP | disclosed |
| CN-105814057-B | Pyrimidines, pyridines and pyrazines as BTK inhibitors and uses thereof | 默克专利有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-105473596-B | Pyrazole compound and application thereof as follicle-stimulating hormone receptor regulator | 默克专利有限公司 | 2019-04-30 | — | — | CN | disclosed |
| CN-109689661-A | Macrocyclic inhibitors of myeloperoxidase | 百时美施贵宝公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109641910-A | Pyrroles acene phenodiazine * and its conjugate | 梅尔莎纳医疗公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-105939998-B | Heteroaryl compound and application thereof as BTK inhibitor | 默克专利有限公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109563075-A | TLR7/8 antagonist and application thereof | 默克专利股份公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-105658650-B | imidazole compounds as modulators of follicle stimulating hormone receptors and uses thereof | 默克专利有限公司 | 2019-01-08 | — | — | CN | disclosed |
| US-20180326121-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR ENHANCING IN VIVO ENGRAFTMENT POTENTIAL | Universite De Paris (FR) | 2018-11-15 | — | — | US | disclosed |
| CN-104628729-B | Antimicrobe compound and its preparation and application | 梅琳塔治疗公司 | 2018-11-06 | — | — | CN | disclosed |
| CN-104768555-B | Combination therapy for the treatment of cancer | EPIZYME股份有限公司 | 2018-10-30 | — | — | CN | disclosed |
| US-20180303772-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR THE TREATMENT OF MYOCARDIAL INFARCTION | Universite De Paris (FR) | 2018-10-25 | — | — | US | disclosed |
| CN-108699032-A | Polycyclic T L R7/8 antagonists and their use in treating immune disorders | 默克专利有限公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108602776-A | Heteroaryl compound and application thereof as IRAK inhibitor | 默克专利有限公司 | 2018-09-28 | — | — | CN | disclosed |
| EP-3377051-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR ENHANCING IN VIVO ENGRAFTMENT POTENTIAL | Institut Pasteur (FR) | 2018-09-26 | — | — | EP | disclosed |
| CN-108473478-A | TBK/IKK inhibitor compounds and uses thereof | 默克专利有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108456211-A | Antimicrobe compound and its preparation and application | 梅琳塔治疗公司 | 2018-08-28 | — | — | CN | disclosed |
| EP-3362058-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR THE TREATMENT OF MYOCARDIAL INFARCTION | Institut Pasteur (FR) | 2018-08-22 | — | — | EP | disclosed |
| CN-108348486-A | 5-hydroxytryptamine 1B receptor agonists as promoters for satellite cell self-renewal and/or differentiation | 巴斯德研究院 | 2018-07-31 | — | — | CN | disclosed |
| US-20180200207-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | Universite De Paris (FR) | 2018-07-19 | — | — | US | disclosed |
| CN-108290879-A | Heteroaryl compound and application thereof as IRAK inhibitor | 默克专利有限公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-108137694-A | ligand of integrin α v β 6 and synthesis and application thereof | 慕尼黑工业大学 | 2018-06-08 | — | — | CN | disclosed |
| CN-108137559-A | Pyrimidine derivatives as BTK inhibitor and application thereof | 默克专利有限公司 | 2018-06-08 | — | — | CN | disclosed |
| US-9988361-B2 | Anti-enterovirus 71 thiadiazolidine derivative | JIANGSU KANION PHARMACEUTICAL CO., LTD. (CN) | 2018-06-05 | — | — | US | disclosed |
| EP-3324952-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | Institut Pasteur (FR) | 2018-05-30 | — | — | EP | disclosed |
| US-20180127389-A1 | Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors | H. LUNDBECK A/S (DK) | 2018-05-10 | — | — | US | disclosed |
| CN-102712647-B | antimicrobial compounds and methods of making and using the same | 梅琳塔治疗公司 | 2018-04-24 | — | — | CN | disclosed |
| CN-107849026-A | Carry alkyl or cycloalkyl P2,Partial factor XI, plasma thromboplastin antecedent A macrocyclic hcv inhibitors | 百时美施贵宝公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-107849055-A | Macrocyclic compound as IRAK1/4 inhibitor and application thereof | 默克专利有限公司 | 2018-03-27 | — | — | CN | disclosed |
| WO-2018011382-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR SKIN AND/OR HAIR REPAIR | INSTITUT PASTEUR (FR) | 2018-01-18 | — | — | WO | disclosed |
| CN-107207476-A | Indoles and 7-azaindole derivatives and its for the purposes in neurodegenerative disorders | 默克专利有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107209186-A | The measure of BTK inhibitor | 默克专利有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107108561-A | Heteroaryl compound as IRAK inhibitor and application thereof | 默克专利有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107074859-A | Indoleamine 2, the diaza and three aza-tricycle compounds of the cyclohexyl-ethyl substitution of 3 dioxygenases (IDO) antagonist are used as treating cancer | 默克专利有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-107001362-A | Heteroaryl compound as BTK inhibitor and application thereof | 默克专利有限公司 | 2017-08-01 | — | — | CN | disclosed |
| US-9708280-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2017-07-18 | — | — | US | disclosed |
| CN-104262345-B | For the CARBA nucleoside analogs of 1 ' substitution of antiviral therapy | 吉利德科学公司 | 2017-06-23 | — | — | CN | disclosed |
| WO-2017100703-A1 | EMS ANALOGUES OF LYN/SRC-TYROSINE KINASE INHIBITORS | COMBS COLIN (US) | 2017-06-15 | — | — | WO | disclosed |
| CN-106687464-A | Macrocyclic RIP2 kinase inhibitors | 昂科迪塞恩股份有限公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-106661056-A | Imidazo-pyridazne derivatives as casein kinase 1 delta/epsilon inhibitors | 百时美施贵宝公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106588890-A | Antiviral compounds | 吉利德制药有限责任公司 | 2017-04-26 | — | — | CN | disclosed |
| CN-103987697-B | Substituted tetrahydroisoquinoline compounds as factor XIA inhibitors | 百时美施贵宝公司 | 2017-04-26 | — | — | CN | disclosed |
| WO-2017063771-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR THE TREATMENT OF MYOCARDIAL INFARCTION | INSTITUT PASTEUR (FR) | 2017-04-20 | — | — | WO | disclosed |
| CN-106563128-A | Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mTOR pathway | 西雅图遗传学公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-106573907-A | Novel quinoline derivatives and their use in neurodegenerative diseases | 默克专利有限公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-106573937-A | Pyrazole compounds as modulators of FSHR and uses thereof | 托口福药业 | 2017-04-19 | — | — | CN | disclosed |
| CN-105732602-B | Benzofuran analogue used as NS4B inhibitor | 常州寅盛药业有限公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-106573077-A | Targeted conjugates and particles and formulations thereof | 塔弗达治疗有限公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-104211713-B | Antiviral compounds | 吉利德制药有限责任公司 | 2017-04-12 | — | — | CN | disclosed |
| CN-105121426-B | Pyrrolidine GPR40 regulators | 百时美施贵宝公司 | 2017-03-29 | — | — | CN | disclosed |
| US-20170066732-A1 | ANTI-ENTEROVIRUS 71 THIADIAZOLIDINE DERIVATIVE | Jiangsu Kanion pharmaceutical CO. LTD (CN) | 2017-03-09 | — | — | US | disclosed |
| EP-3138840-A1 | ANTI-ENTEROVIRUS 71 THIADIAZOLIDINE DERIVATIVE | Jiangsu Kanion Pharmaceutical Co., Ltd. (CN) | 2017-03-08 | — | — | EP | disclosed |
| WO-2017013031-A1 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | INSTITUT PASTEUR (FR) | 2017-01-26 | — | — | WO | disclosed |
| CN-103261156-B | For treating the noval chemical compound of neurodegenerative disease | 鲁汶天主教大学研究开发部 | 2016-12-28 | — | — | CN | disclosed |
| CN-106255679-A | As Naheterocyclic compound of V channel inhibitor and application thereof | 默克专利有限公司 | 2016-12-21 | — | — | CN | disclosed |
| CN-106068264-A | PYRIMIDINE PYRAZOLYL DERIVATIVES AND THEIR USE AS IRAK INHIBITORS | 默克专利有限公司 | 2016-11-02 | — | — | CN | disclosed |
| CN-103561759-B | Synergistic effect between AURISTATIN (AURISTATIN) -based antibody drug conjugates and PI3K-AKT mTOR pathway inhibitors | 西雅图遗传学公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-105980375-A | Pyrimidine imidazole amines as modulators of kinase activity | 默克专利有限公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105939998-A | Heteroaryl compounds as btk inhibitors and uses thereof | 默克专利有限公司 | 2016-09-14 | — | — | CN | disclosed |
| CN-102884049-B | Heterocyclic amides useful as ROCK inhibitors | 阿玛克姆股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-105814032-A | Synthesis of 1-alkyl-2-amino-imidazole-5-carboxylic acid esters by C alpha-substituted N-alkyl-glycine ester derivatives | 默克专利有限公司 | 2016-07-27 | — | — | CN | disclosed |
| US-20160137620-A1 | Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors | H. LUNDBECK A/S (DK) | 2016-05-19 | — | — | US | disclosed |
| US-9156937-B2 | Block polyisocyanate composition and coating composition containing same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-9090575-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2015-07-28 | — | — | US | disclosed |
| US-9067955-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-06-30 | — | — | US | disclosed |
| US-8962830-B2 | Protein kinase inhibitors and methods of treatment | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2015-02-24 | — | — | US | disclosed |
| EP-2535364-B1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | ASAHI KASEI CHEMICALS CORP (JP) | 2015-01-21 | — | — | EP | disclosed |
| CN-101784532-B | Novel HIV reverse transcriptase inhibitors | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2014-10-22 | — | — | CN | disclosed |
| US-20140163043-A1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. LUNDBECK A/S (DK) | 2014-06-12 | — | — | US | disclosed |
| CN-102753596-B | Block polyisocyanate composition and coating composition containing same | ASAHI KASEI CHEMICALS CORP | 2014-03-26 | — | — | CN | disclosed |
| US-20130184274-A1 | Protein Kinase Inhibitors and Methods of Treatment | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2013-07-18 | — | — | US | disclosed |
| US-8476279-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2013-07-02 | — | — | US | disclosed |
| EP-2590982-A1 | PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT | The Walter and Eliza Hall Institute of Medical Research (AU) | 2013-05-15 | — | — | EP | disclosed |
| EP-2535364-A1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | Asahi Kasei Chemicals Corporation (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316291-A1 | BLOCK POLYISOCYANATE COMPOSITION AND COATING COMPOSITION CONTAINING SAME | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20120302553-A1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. LUNDBECK A/S (DK) | 2012-11-29 | — | — | US | disclosed |
| CN-102770456-A | Multispecific antibodies, antibody analogs, compositions and methods | GENENTECH INC | 2012-11-07 | — | — | CN | disclosed |
| CN-102741258-A | Compositions and methods of cyclofructans as separating agents | UNIV TEXAS | 2012-10-17 | — | — | CN | disclosed |
| CN-101031570-B | Inhibitors of VEGF receptor and HGF receptor signaling | METHYLGENE INC | 2012-09-05 | — | — | CN | disclosed |
| EP-2475657-A1 | INHIBITORS OF FLAVIVIRIDAE VIRUSES | Gilead Sciences, Inc. (US) | 2012-07-18 | — | — | EP | disclosed |
| CN-102596958-A | 2' -fluoro CARBA-nucleoside analogs for antiviral treatment | GILEAD SCIENCES INC | 2012-07-18 | — | — | CN | disclosed |
| CN-102471380-A | anti-FcRH 5 antibodies and immunoconjugates and methods of use | GENENTECH INC | 2012-05-23 | — | — | CN | disclosed |
| CN-101816664-B | Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases | GILEAD SCIENCES INC | 2012-04-18 | — | — | CN | disclosed |
| CN-102369218-A | Anti-fcrh5 antibodies and immunoconjugates and methods of use | GENENTECH INC | 2012-03-07 | — | — | CN | disclosed |
| US-8110567-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2012-02-07 | — | — | US | disclosed |
| WO-2012003544-A1 | PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2012-01-12 | — | — | WO | disclosed |
| WO-2011128374-A1 | INSULIN-SIRNA CONJUGATES | SANOFI (FR) | 2011-10-20 | — | — | WO | disclosed |
| CN-101210016-B | Heterocycle-fused morphinans compounds, preparation method and use thereof | SHANGHAI INST MATERIA MEDICA | 2011-07-20 | — | — | CN | disclosed |
| CN-102015675-A | Chlorothiophene amides as inhibitors of coagulation factors Xa and thrombin | SANOFI AVENTIS | 2011-04-13 | — | — | CN | disclosed |
| CN-102014964-A | Compositions and methods for treating tumors of hematopoietic origin | GENENTECH INC | 2011-04-13 | — | — | CN | disclosed |
| CN-101981035-A | Triazolium salts as PAR1 inhibitors, their preparation and their use as medicaments | SANOFI AVENTIS | 2011-02-23 | — | — | CN | disclosed |
| WO-2011011303-A1 | INHIBITORS OF FLAVIVIRIDAE VIRUSES | GILEAD SCIENCES, INC. (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20110009423-A1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. LUNDBECK A/S (DK) | 2011-01-13 | — | — | US | disclosed |
| US-7683053-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2010-03-23 | — | — | US | disclosed |
| US-7612068-B2 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | H. LUNDBECK A/S (DK) | 2009-11-03 | — | — | US | disclosed |
| EP-1749818-B1 | Phenyl-piperidine derivatives as serotonin reuptake inhibitors | LUNDBECK & CO AS H (DK) | 2009-09-02 | — | — | EP | disclosed |
| CN-100457738-C | Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives | LUNDBECK & CO AS H (DK) | 2009-02-04 | — | — | CN | disclosed |
| CN-101210016-A | Heterocycle-fused morphinans compounds, preparation method and use thereof | SHANGHAI INST OF MEDICINE CHIN (CN) | 2008-07-02 | — | — | CN | disclosed |
| US-20080146540-A1 | Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association | DECODE GENETICS EHF. (IS) | 2008-06-19 | — | — | US | disclosed |
| CN-101203230-A | Modulation of angiogenesis with NOD factors such as glucosamine oligosaccharides | RICHARD PARISH CHRISTOPHER (AU) | 2008-06-18 | — | — | CN | disclosed |
| US-7371863-B2 | Method for manufacture of THIP | H. LUNDBECK A/S (DK) | 2008-05-13 | — | — | US | disclosed |
| EP-1436271-B1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | LUNDBECK & CO AS H (DK) | 2008-02-20 | — | — | EP | disclosed |
| WO-2007147222-A9 | NOVEL IONIC LIQUIDS | UNIV LEUVEN KATH (BE) | 2008-02-14 | — | — | WO | disclosed |
| WO-2007147222-A2 | NOVEL IONIC LIQUIDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2007-12-27 | — | — | WO | disclosed |
| EP-1109552-A4 | NOVEL DNA-CLEAVING ANTITUMOR AGENTS | RES DEV FOUNDATION (US) | 2007-11-07 | — | — | EP | disclosed |
| EP-1848436-A2 | METHODS OF DIAGNOSIS AND TREATMENT FOR ASTHMA, ALLERGIC RHINITIS AND OTHER RESPIRATORY DISEASES BASED ON HAPLOTYPE ASSOCIATION | Decode Genetics EHF. (IS) | 2007-10-31 | — | — | EP | disclosed |
| EP-1390340-A4 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-07-25 | — | — | EP | disclosed |
| CN-1972920-A | Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms | WYETH CORP (US) | 2007-05-30 | — | — | CN | disclosed |
| US-20070112198-A1 | Method for manufacture of thip | H.LUNDBECK A/S (DK) | 2007-05-17 | — | — | US | disclosed |
| CN-1950383-A | Phosphonates, monophosphonamides, bisphosphonates for the treatment of viral diseases | GILEAD SCIENCES INC (US) | 2007-04-18 | — | — | CN | disclosed |
| EP-1458689-B1 | ARYLOXYPHENYL AND ARYLSULFANYLPHENYL DERIVATIVES | LUNDBECK & CO AS H (DK) | 2007-04-11 | — | — | EP | disclosed |
| US-20070060574-A1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. LUNDBECK A/S (DK) | 2007-03-15 | — | — | US | disclosed |
| EP-1749818-A2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. Lundbeck A/S (DK) | 2007-02-07 | — | — | EP | disclosed |
| US-7148238-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2006-12-12 | — | — | US | disclosed |
| EP-1727785-A1 | PHENYL INDAN DERIVATIVES | H.Lundbeck A/S (DK) | 2006-12-06 | — | — | EP | disclosed |
| US-7144884-B2 | E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. | H. LUNDBECK A/S (DK) | 2006-12-05 | — | — | US | disclosed |
| US-20060264673-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-11-23 | — | — | US | disclosed |
| US-7138407-B2 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2006-11-21 | — | — | US | disclosed |
| CN-1854128-A | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-11-01 | — | — | CN | disclosed |
| US-20060235003-A1 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | H. LUNDBECK A/S (DK) | 2006-10-19 | — | — | US | disclosed |
| US-7115784-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-10-03 | — | — | US | disclosed |
| WO-2006081555-A2 | METHODS OF DIAGNOSIS AND TREATMENT FOR ASTHMA, ALLERGIC RHINITIS AND OTHER RESPIRATORY DISEASES BASED ON HAPLOTYPE ASSOCIATION | DECODE GENETICS EHF. (IS) | 2006-08-03 | — | — | WO | disclosed |
| CN-1266112-C | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-07-26 | — | — | CN | disclosed |
| US-7067501-B2 | Aryloxyphenyl and arylsulfanylphenyl derivatives | H. LUNDBECK A/S (DK) | 2006-06-27 | — | — | US | disclosed |
| US-20060089368-A1 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2006-04-27 | — | — | US | disclosed |
| US-20060084662-A1 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2006-04-20 | — | — | US | disclosed |
| EP-1646372-A2 | METHODS OF DIAGNOSIS AND TREATMENT FOR ASTHMA BASED ON HAPLOTYPE ASSOCIATION | Decode Genetics EHF. (IS) | 2006-04-19 | — | — | EP | disclosed |
| EP-1622868-A1 | AROMATIC OXYPHENYL AND AROMATIC SULFANYLPHENYL DERIVATIVES | H. LUNDBECK A/S (DK) | 2006-02-08 | — | — | EP | disclosed |
| US-20060014165-A1 | Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association | DECODE GENETICS EHF. (IS) | 2006-01-19 | — | — | US | disclosed |
| US-20050215794-A1 | Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-09-29 | — | — | US | disclosed |
| WO-2005087708-A1 | PHENYL INDAN DERIVATIVES | H. LUNDBECK A/S (DK) | 2005-09-22 | — | — | WO | disclosed |
| US-20050171061-A1 | Aryloxyphenyl and arylsulfanylphenyl derivatives | H. LUNDBECK A/S (DK) | 2005-08-04 | — | — | US | disclosed |
| US-6908948-B1 | DNA-cleaving antitumor agents | RESEARCH DEVELOPMENT FOUNDATION (US) | 2005-06-21 | — | — | US | disclosed |
| CN-1606548-A | Aryloxyphenyl and Arylthiophenyl Derivatives | LUNDBECK & CO AS H (DK) | 2005-04-13 | — | — | CN | disclosed |
| US-6867298-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2005-03-15 | — | — | US | disclosed |
| WO-2005007144-A2 | METHOD OF DIAGNOSIS AND TREATMENT FOR ASTHMA BASED ON HAPLOTYPE ASSOCIATION | DECODE GENETICS EHF (IS) | 2005-01-27 | — | — | WO | disclosed |
| US-20050014740-A1 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | H. LUNDBECK A/S (DK) | 2005-01-20 | — | — | US | disclosed |
| US-20040247523-A1 | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-12-09 | — | — | US | disclosed |
| EP-1479676-A1 | Benzimidazole-derivatives as factor xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | disclosed |
| WO-2004096761-A1 | AROMATIC OXYPHENYL AND AROMATIC SULFANYLPHENYL DERIVATIVES | H. LUNDBECK A/S (DK) | 2004-11-11 | — | — | WO | disclosed |
| EP-1458689-A1 | ARYLOXYPHENYL AND ARYLSULFANYLPHENYL DERIVATIVES | H. LUNDBECK A/S (DK) | 2004-09-22 | — | — | EP | disclosed |
| CN-1518534-A | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | 麻省理工学院 | 2004-08-04 | — | — | CN | disclosed |
| US-6770259-B2 | ADMINISTEING RADIOLABELED LEUKOTRIENE (LTB4) BINDING AGENT AND A RADIOLABELED PERFUSION IMAGING AGENT; CONCURRENTLY DETECTING THE RADIOLABELED LTB4 BINDING AGENT BOUND AT THE LTB4 RECEPTOR AND THE RADIOLABELED PERFUSION IMAGING AGENT | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-08-03 | — | — | US | disclosed |
| EP-1436271-A1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. Lundbeck A/S (DK) | 2004-07-14 | — | — | EP | disclosed |
| US-6759554-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2004-07-06 | — | — | US | disclosed |
| EP-1390340-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6686345-B2 | INCLUDES AN AZA-ENEDIYNE, AZA-ENYNE ALLENE, OR AN AZA-DIALLENE; ARE PREFERABLY NON-HYDROLYZABLE, CATIONIC COMPOUNDS THAT BIND TO NUCLEIC ACIDS. | RESEARCH DEVELOPMENT FOUNDATION | 2004-02-03 | — | — | US | disclosed |
| US-20040019216-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-01-29 | — | — | US | disclosed |
| WO-2003099810-A2 | RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |
| US-20030152512-A1 | Imaging thrombus with glycoprotein llb/llla antagonists | BRISTOL-MYERS SQUIBB PHARMA COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2003-08-14 | — | — | US | disclosed |
| WO-2003064428-A1 | FURANO- AND THIENOPYRIMIDINES AS NEUROKINASE INHIBITORS | H. LUNDBECK A/S (DK) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003053942-A1 | ARYLOXYPHENYL AND ARYLSULFANYLPHENYL DERIVATIVES | H. LUNDBECK A/S (DK) | 2003-07-03 | — | — | WO | disclosed |
| US-20030124053-A1 | Radiopharmaceuticals for imaging infection and inflammation | BRISTOL-MYERS SQUIBB COMPANY | 2003-07-03 | — | — | US | disclosed |
| EP-0888130-B1 | NEW TERNARY RADIOPHARMACEUTICAL COMPLEXES | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2003-07-02 | — | — | EP | disclosed |
| EP-0999856-B1 | RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2003-05-14 | — | — | EP | disclosed |
| WO-2003029232-A1 | PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS | H. LUNDBECK A/S (DK) | 2003-04-10 | — | — | WO | disclosed |
| US-20030065187-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-03 | — | — | US | disclosed |
| EP-1293214-A2 | LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation | Bristol-Myers Squibb Pharma Company (US) | 2003-03-19 | — | — | EP | disclosed |
| US-20030007927-A1 | Radiopharmaceuticals for imaging infection and inflammation | BARRETT JOHN A (US) | 2003-01-09 | — | — | US | disclosed |
| US-20030003049-A1 | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation | LANTHEUS MEDICAL IMAGING, INC. | 2003-01-02 | — | — | US | disclosed |
| WO-2002085838-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-10-31 | — | — | WO | disclosed |
| US-20020132797-A1 | DNA-cleaving antitumor agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-19 | — | — | US | disclosed |
| EP-0820312-B1 | TERNARY RADIOPHARMACEUTICAL COMPLEXES | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2002-07-10 | — | — | EP | disclosed |
| US-6416733-B1 | RADIOPHARMACEUTICALS BIND IN VIVO TO THE LEUKOTRIENE B4 (LTB4) RECEPTOR ON THE SURFACE OF LEUKOCYTES WHICH ACCUMULATE AT THE SITE OF INFECTION AND INFLAMMATION | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-07-09 | — | — | US | disclosed |
| CN-1356913-A | vitronectin receptor antagonist drugs | DU PONT PHARM CO (US) | 2002-07-03 | — | — | CN | disclosed |
| CN-1348373-A | Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis | HOLLIS EDEN PHARMACEUTICALS (US) | 2002-05-08 | — | — | CN | disclosed |
| EP-1195168-A2 | Ternary radiopharmaceutical complexes | Dupont Pharmaceuticals Company (US) | 2002-04-10 | — | — | EP | disclosed |
| US-6297284-B1 | AZA-ENEDIYNE, AZA-ENYNE ALLENE, OR AN AZA-DIALLENE CATIONIC COMPOUNDS THAT BIND TO NUCLEIC ACIDS. | RESEARCH DEVELOPMENT FOUNDATION | 2001-10-02 | — | — | US | disclosed |
| WO-2001070217-A1 | DNA-CLEAVING ANTITUMOR AGENTS | RESEARCH DEVELOPMENT FOUNDATION (US) | 2001-09-27 | — | — | WO | disclosed |
| EP-1109552-A1 | NOVEL DNA-CLEAVING ANTITUMOR AGENTS | RESEARCH DEVELOPMENT FOUNDATION (US) | 2001-06-27 | — | — | EP | disclosed |
| CN-1272105-A | Compound containing six-membered rings, processes for their preparation, and their use as medicaments | GILEAD SCIENCES INC (US) | 2000-11-01 | — | — | CN | disclosed |
| WO-2000003709-A9 | NOVEL DNA-CLEAVING ANTITUMOR AGENTS | UNIV TEXAS (US) | 2000-07-20 | — | — | WO | disclosed |
| EP-0692982-B1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | DU PONT PHARM CO (US) | 2000-07-05 | — | — | EP | disclosed |
| US-6056958-A | Method of treatment of arterial and venous thromboembolic disorders | DUPONT PHARMACEUTICALS (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0995761-A2 | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | Dupont Pharmaceuticals Company (US) | 2000-04-26 | — | — | EP | disclosed |
| US-6022523-A | NOVEL CYCLIC COMPOUNDS CONTAINING CARBOCYCLIC AND HETEROCYCLIC RING SYSTEMS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-02-08 | — | — | US | disclosed |
| WO-2000003709-A1 | NOVEL DNA-CLEAVING ANTITUMOR AGENTS | RESEARCH DEVELOPMENT FOUNDATION (US) | 2000-01-27 | — | — | WO | disclosed |
| US-6015904-A | HYDRAZONE-MODIFIED BIOLOGICALLY ACTIVE MOLECULES WHICH REACT WITH GAMMA-EMITTING RADIOISOTOPES AND FORM COMPOUNDS WHICH SELECTIVELY BIND AT DISEASE SITES FOR IMAGING BY GAMMA SCINTIGRAPHY | LANTHEUS MEDICAL IMAGING, INC. | 2000-01-18 | — | — | US | disclosed |
| US-6010679-A | TRANSITION METAL RADIONUCLEOLIDE; CONTRAST AGENTS FOR DIAGNOSING CARDIOVASCULAR DISORDERS, CANCER | LANTHEUS MEDICAL IMAGING, INC. | 2000-01-04 | — | — | US | disclosed |
| US-5888970-A | DIAGNOSIS OF ARTERIAL AND VENOUS THROMBOSIS | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-03-30 | — | — | US | disclosed |
| US-5879659-A | IMAGES FOR DIAGNOSIS OF CARDIOVASCULAR DISORDERS | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-03-09 | — | — | US | disclosed |
| US-5879657-A | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0888130-A2 | NEW TERNARY RADIOPHARMACEUTICAL COMPLEXES | Du Pont Pharmaceuticals Company (US) | 1999-01-07 | — | — | EP | disclosed |
| CN-1202893-A | Novel isoxazoline and isoxazole fibrinogen receptor antagonists | DU PONT MERCK PHARMA (US) | 1998-12-23 | — | — | CN | disclosed |
| US-5849693-A | Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIa | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| CN-1192733-A | Stable reagent for prepn. of radiopharmaceuticals | PONT MERCH PHARMACEUTICAL CO D (US) | 1998-09-09 | — | — | CN | disclosed |
| US-5773411-A | CARDIOVASCULAR DISORDERS AND BRAIN DISORDERS AND COAGULANTS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-06-30 | — | — | US | disclosed |
| US-5750088-A | IMAGING AGENTS FOR DIAGNOSIS OF CARDIOVASCULAR DISORDERS,INFECTIONS, INFLAMMATION, CANCER | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5744120-A | PHOSPHINE OR ARSINE LIGATED TECHNETIUM-99M LABELED HYDRAZINO OR DIAZINO MODIFIED BIOLOGICALLY ACTIVE MOLECULES THAT SELECTIVELY LOCALIZE AT SITES OF DISEASE | THE DUPONT MERICK PHARMACEUTICAL COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| EP-0692982-A4 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | DU PONT MERCK PHARMA (US) | 1998-03-11 | — | — | EP | disclosed |
| US-5635477-A | CYCLIC TETRAPEPTIDE DERIVATIVE FUSED TO A BENZENE RING; ANTICOAGULANTS; THROMBOLYTICS; CLOT LYSIS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-06-03 | — | — | US | disclosed |
| CN-1122577-A | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | DU PONT MERCK PHARMA (US) | 1996-05-15 | — | — | CN | disclosed |
| EP-0692982-A1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-01-24 | — | — | EP | disclosed |
| WO-1995023811-A1 | NOVEL CARBOCYCLIC COMPOUNDS WHICH INHIBIT PLATELET AGGREGATION BY INTERACTION WITH THE GPIIB/IIIA RECEPTOR COMPLEX | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-09-08 | — | — | WO | disclosed |
| WO-1994022494-A1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022910-A1 | CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994011398-A1 | CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-05-26 | — | — | WO | disclosed |
| EP-0125209-B1 | LUBRICATING COMPOSITIONS | CIBA-GEIGY AG (CH) | 1987-07-29 | — | — | EP | disclosed |
| US-4544492-A | THIOPHOSPHORIC ACID ESTER DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1985-10-01 | — | — | US | disclosed |
| US-4544492-A | THIOPHOSPHORIC ACID ESTER DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1985-10-01 | — | — | US | disclosed |